SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
LEXG-Lexicon Genetics
An SI Board Since August 2000
Posts SubjectMarks Bans Symbol
254 32 0 LXRX
Emcee:  rkrw Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
2544211 continues to do well in trials. This one is for T2 and renal impairment...pgo-neil-10/1/2013
2534211 continues to perform. >>THE WOODLANDS, Texas, June 25, 2012 /PRNewstuck-6/26/2012
252Filed $200M shelf registration yesterday. google.brand.edgar-online.comD.Lu-1/29/2011
251>>Lexicon Announces Positive Results from New Clinical Study of LX4211 in tuck-1/6/2011
250LXRX press release indicates progress in all 3 Ph2 candidates. They have enoughpgo-neil-11/5/2010
249I caught the action yesterday......heavy spike in volume and biggest one day movArthur Radley-10/1/2010
248Noticed it bumping up prior to the announcement. Hope the share price holds andD.Lu-10/1/2010
247J.P. Morgan Initiates Coverage on Biotechnology Stocks (LXRX & IMGN) 9:19 amArthur Radley-10/1/2010
246August 6, 2010 Price History With Technical And Fundamental Ri Ned Davis ResearcArthur Radley-8/9/2010
245Stock is showing some spunk today.....maybe the news is being taken as a positivArthur Radley-8/3/2010
244Strange reaction to the news....traded flat, then moved up, and then back to flaArthur Radley-8/2/2010
243Lexicon buys back [with time payments], all rights to 1031/2/3 from Symphony. Inpgo-neil-8/2/2010
242LX4211 Positive Phase 2a Clinical Results in Type 2 diabetes finance.yahoo.comD.Lu-6/21/2010
241Bought back in today......@$1.43-1.45 level with target of $1.60 where the wall Arthur Radley-5/25/2010
240"Synthesis and SAR of Benzisothiazole- and Indolizine-ß-d-glucopyranostuck-4/9/2010
239A lot of size is coming in on the bid........volume seems to be picking up. I waArthur Radley-4/6/2010
238Schwab alert at the close......."Stock moved above 200 day moving average..Arthur Radley-3/30/2010
237blogs.wsj.com Nice mention of LXRX and a couple more biotechs....in the Wall StArthur Radley-3/24/2010
236Isn't Symphony the brainchild of the CEO...and he sits on their board? If soArthur Radley-3/17/2010
235Speculation on YMB (thanks to mono1ceros) is that they might need some of the caD.Lu-3/17/2010
234mffais.com On a cursory look, it appears that funds have been adding share lateArthur Radley-3/16/2010
233It's insane how much money INVUS must have and is investing in Lexicon. I dorkrw13/16/2010
232This part of the 2007 deal indicates that Invus forced this latest secondary, hoArthur Radley-3/16/2010
231Invus initial purchases were for $3.09 and 4.50. So they're doubling down. rkrw13/16/2010
230Huge amount of money and dilution, but when one looks at the players ---especialArthur Radley-3/16/2010
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News